MPLT
MapLight Therapeutics, Inc.
$37.33
-0.58 (-1.53%)
At close · Jul 15
Market Cap
$1.69B
Shares
45,345,676
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$37.33
Open$37.54
Day$35.52–37.78
52W$12.24–40.43
Avg vol 30d460K
Short int2.6M · 5.7% float · 4.0d
Short vol63%
DataOct 2025–Jul 2026
Filing10-Q · May 14
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 14, 2026
Equibles Rating
blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 15.7 · calm
Equity put/call 0.69
Technical
price trend
50 / 200-day cross
No cross
Price vs 50-day avg
+21%
above
RSI (14)
60
neutral
MACD trend
Positive
52-week position
89%
near high
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+37%
trailing
6-month return
+120%
trailing
YTD return
+113%
this year
Relative strength
+110%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Accumulating
2 of 80 funds reported for Jun 30 · net +29 sh shares
Insider flow
Distributing
Net -$14.9M over 90 days · 100% sells
Short interest
Rising
5.68% of float · ▲ +35.7% MoM · 4.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
80 holders — 13F breadth
Squeeze score
72
high risk · 0–100
Fundamentals
EPS growth
+82%
Y/Y
Free cash flow
$-138.6M
Balance sheet
$46.7M
net cash
Quant / Vol
risk profile
Volatility
87%
annualized · 1-yr
Max drawdown
−30%
past year
ATR
7.4%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 50-day avg
+21%
Bullish
RSI (14)
60
Neutral
MACD trend
Positive
Bullish
52-week position
89%
Bullish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Accumulating
2 of 80 funds reported for Jun 30 · net +29 sh shares
Insider flow
Distributing
Net -$14.9M over 90 days · 100% sells
Short interest
Rising
5.68% of float · ▲ +35.7% MoM · 4.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
80 holders — 13F breadth
Price context
position in its 52-week range
52-wk low $12
Now $37 · 89%
52-wk high $40
vs 50-day avg +21%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
MPLT
this stock
MapLight Therapeutics, Inc.
|
$1.69B | +112.5% | — | — | 5.7% |
|
ONC
BeOne Medicines Ltd.
|
$449.85B | +2.5% | +22179.2% | 915.5 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$121.09B | +5.2% | +46.2% | 28.3 | 1.9% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.66B | -13.8% | +20.8% | 16.2 | 3.3% |
|
ARGX
Argenx SE
|
$53.96B | +2.6% | — | — | 2.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| MPLT | -3.1% | +36.7% | +120.2% | +4.2% | +112.5% |
| SPY | +1.3% | -0.2% | +10.1% | +1.1% | +10.7% |
| vs SPY | -4.4% | +36.9% | +110.1% | +3.1% | +101.8% |